CKBSG - "FREON" 114
- MSDS: CKBSG
- Manufacturer: DUPONT
- Product Name: "FREON" 114
- National Stock Number: 6830-00-782-6232
Product Identification
Product ID:"FREON" 114
MSDS Date:01/07/1997
FSC:6830
NIIN:00-782-6232
Status Code:A
MSDS Number: CKBSG
Responsible Party
WILMINGTON, DE 19898-5000
US
Emergency Phone: 800-441-3637
Info Phone: 800-441-3637
Cage: EO596
Contractor
Telephone: 800-441-3637-MED 800-424-9300-TRAN
Cage: 5P414
Ingredients
1,2-DICHLORO-1,1,2,2-TETRAFLUOROETHANE ("FREON"114)
CAS: 76-14-2
RTECS: KI1101000
OSHA PEL 7000 MG/M3;1000 PPM
ACGIH TLV: 6990 MG/M3;1000 PPM
Hazards
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:INHALATION OF HIGH CONCENTRATIONS OF
VAPOR IS HARMFUL & MAY CAUSE HEART IRREGULARITIES, UNCONSCIOUSNESS
OR DEATH. INTENTIONAL MISUSE OR DELIBERATE INHALATION MAY CAUSE
DEATH WITHOUT WARNING. VAPOR RED UCES OXYGEN AVAILABLE FOR
BREATHING & IS HEAVIER THAN AIR. LIQUID CONTACT CAN CAUSE
FROSTBITE.
Explanation of Carcinogenicity:NONE OF THE COMPONENTS PRESENT IN THIS
MATERIAL AT CONCENTRATIONS EQUAL TO OR GREATER THAN 0.1 % ARE
LISTED BY IARC, NTP, OSHA OR ACGIH AS A CARCINOGEN.
Effects of Overexposure:OVEREXPOSURE BY SKIN OR EYE CONTACT MAY INCLUDE
SKIN IRRITATION WITH DISCOMFORT OR RASH, OR EYE IRRITATION WITH
DISCOMFORT, TEARING, OR BLURRING OF VISION. CONTACT WITH LIQUID MAY
CAUSE FROSTBITE. OVE REXPOSURE BY INHALATION OF THE VAPORS MAY
CAUSE NONSPECIFIC DISCOMFORT SUCH AS NAUSEA, HEADACHE OR WEAKNESS.
TEMPORARY ALTERATION OF THE HEART'S ELECTRICAL ACTIVITY WITH
IRREGULAR PAUSE. PALPITATIONS, OR INADEQUATE CIRCULATION.
Medical Cond Aggravated by Exposure:INDIVIDUALS WITH PREEXISTING
DISEASES OF THE CENTRAL NERVOUS OR CARDIOVASCULAR SYSTEM MAY HAVE
INCREASED SUSCEPTIBILITY TO THE TOXICITY OF EXCESSIVE EXPOSURES.
First Aid
First Aid:INHALATION: MOVE TO FRESH AIR. IF NOT BREATHING, GIVE
ARTIFICIAL RESPIRATION. IF BREATHING IS DIFFICULT, GIVE OXYGEN.
CALL A PHYSICIAN. SKIN: FLUSH WITH WATER. TREAT FOR FROSTBITE IF
NECESSARY. GET ME DICAL ATTENTION IF IRRITATION IS PRESENT. EYE:
IMMEDIATELY FLUSH EYES WITH PLENTY OF WATER FOR AT LEAST 15 MINS.
CALL A PHYSICIAN. INGESTION: INGESTION IS NOT CONSIDERED A
POTENTIAL ROUTE OF EXPOSURE. NOTE TO PHYSICIAN: BECAUSE OF
POSSIBLE DISTURBANCES OF CARDIAC RHYTHM, CATECHOLAMINE DRUGS, SUCH
AS EPINEPHRINE SHOULD BE USED WITH SPECIAL CAUTION IN SITUATIONS OF
EMERGENCY LIFE SUPPORT.
Fire Fighting
Flash Point Method:TOC
Flash Point:WILL NOT BURN
Autoignition Temp:Autoignition Temp Text:N/D
Extinguishing Media:AS APPROPRIATE FOR COMBUSTIBLES IN AREA.
Fire Fighting Procedures:SELF CONTAINED BREATHING APPARATUS (SCBA) IS
REQUIRED IF CYLINDERS RUPTURE OR RELEASE CONTENTS UNDER FIRE
CONDITIONS. USE WATER SPRAY OR FOG TO COOL CONTAINERS.
Unusual Fire/Explosion Hazard:CYLINDERS ARE EQUIPPED WITH PRESSURE &
TEMPERATURE RELIEF DEVICES, BUT STILL MAY RUPTURE UNDER FIRE
CONDITIONS. DECOMPOSITION MAY OCCUR.
Accidental Release
Spill Release Procedures:VENTILATE AREA, ESPECIALLY LOW PLACES WHERE
HEAVY VAPORS MIGHT COLLECT. REMOVE OPEN FLAMES. USE SELF CONTAINED
BREATHING APPARATUS (SCBA) IN CASE OF LARGE SPILLS. COMPLY WITH
FEDERAL, STATE, & LOCAL R EGULATIONS ON REPORTING RELEASES. REVIEW
FIRE FIGHTING MEASURES AND HANDLING SECTION BEFORE PROCEEDING WITH
CLEAN-UP. USE APPROPRIATE PERSONAL PROTECTIVE EQUIPMENT DURING
CLEAN-UP.
Neutralizing Agent:NONE PROVIDED BY MFR.
Handling
Handling and Storage Precautions:STORAGE: CLEAN, DRY AREA. DO NOT HEAT
ABOVE 125 DEG F. AVOID BREATHING VAPORS & CONTACT OF LIQUID WITH
SKIN OR EYES. USE WITH SUFFICIENT VENTILATION TO KEEP EMPLOYEE
EXPOSURE BELOW RECOMMENDED LIMITS.
Other Precautions:NONE PROVIDED BY MFR.
Exposure Controls
Respiratory Protection:UNDER NORMAL MANUFACTURING CONDITIONS, NO
RESPIRATORY PROTECTION IS REQUIRED WHEN USING THIS PRODUCT. SELF
CONTAINED BREATHING APPARATUS (SCBA) IS REQUIRED IF A LARGE RELEASE
OCCURS.
Ventilation:NORMAL VENTILATION IS GENERALLY ADEQUATE. LOCAL EXHAUST
SHOULD BE USED FOR LARGE RELEASES. MECHANICAL FOR LOW OR ENCLOSED
PLACES.
Protective Gloves:IMPERVIOUS GLOVES IF LIQUID CONTECT WITH SKIN IS
POSSIBLE.
Eye Protection:USE CHEMICAL SPLASH GOGGLES AS NEEDED TO PREVENTLIQUID
CONTACT WITH THE EYES.
Other Protective Equipment:NONE PROVIDED BY MFR.
Work Hygienic Practices:NONE PROVIDED BY MFR.
Supplemental Safety and Health
EXPOSURE GUIDELINES: EXPOSURE LIMITS FOR "FREON" 114: PEL (OSHA) =
1,000 PPM, 7,000 MG/M3, 8 HR. TWA. TLV (ACGIH) = 1,000 PPM, 6,990
MG/M3, 8 HR. TWA, A4.
Chemical Properties
HCC:G3
Boiling Pt:=4.C, 39.2F
Decomp Temp:=593.C, 1099.4F
Decomp Text:AUTODECOMPOSITION
Vapor Pres:31 PSIA @ 25 DEG C (77 F)
Vapor Density:6.2(AIR=1)
Spec Gravity:1.46 @77F- LIQUID
Evaporation Rate & Reference:> 1 (CC14 = 1.0)
Solubility in Water:0.013 WT% @ 25 DEG C
Appearance and Odor:LIQUEFIED GAS, CLEAR, COLORLESS, SLIGHT ETHEREAL
ODOR
Percent Volatiles by Volume:100 WT%
Stability
Stability Indicator/Materials to Avoid:YES
INCOMPATIBLE WITH ALKALI OR ALKALINE EARTH METALS - POWDERED AL, ZN,
BE, ETC.
Stability Condition to Avoid:MATERIAL IS STABLE. HOWEVER, AVOID OPEN
FLAMES AND HIGH TEMPERATURES.
Hazardous Decomposition Products:DECOMPOSITION PRODUCTS ARE
HAZARDOUS."FREON" 114 CAN DECOMPOSE AT HIGH TEMPERATURES (OPEN
FLAMES, GLOWING METAL SURFACE, ETC.) FORMINGHYDROCHLORIC AND
HYDROFLUORIC ACIDS, AND POSSIBLY CARBONYL HALIDES.
Conditions to Avoid Polymerization:WILL NOT OCCUR
Disposal
Waste Disposal Methods:COMPLY WITH FEDERAL, STATE & LOCAL REGULATIONS.
RECLAIM BY DISTILATION OR REMOVE TO A LICENSED WASTE DISPOSAL
FACILITY.
Toxicology
Toxicological Information:ANIMAL DATA: INHALATION 0.5-HR LC50: 720,000
PPM IN RATS. ORAL ALD: >2250 MG/KG IN RATS. COMPOUND IS MILD SKIN
AND EYE IRRITANT, UNTESTED FOR ANIMAL SENSITIZATION. TOXIC EFFECTS
DESCRIBED IN ANIMAL E XPOSURES BY INHALATION OR INGESTION INCLUDE
CNS EFFECTS, CARDIAC SENSITIZATION, RESPIRATORY AND LIVER EFFECTS.
MICE EXPOSED FOR 23 MONTHS TO MIX OF CHLOROFLUORO CARBONS INCLUDING
250,000 PPM OF "FREON " 114, DEMONSTRATED NO EVIDENCE OF
CARCINOGENIC ACTIVITY. NO ANIMAL TEST REPORTS DEFINE EMBRYOTOXIC,
OR REPRODUCTIVE HAZARDS.TESTS IN BACTERIAL OR MAMMALIAN CELL
CULTURES DEMONSTRATE NO MUTAGENIC ACT IVITY.
Other Information
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ecology
Ecological:AQUATIC TOXICITY: 96-HOUR LC50, KILLIFISH: 45 PPM.
Transport
Transport Information:SHIPPING INFORMATION: DOT/ IMO/ IATA: PROPER
SHIPPING NAME: 1,2-DICHLORO-1,1,1,1-TETRAFLUOROETHANE, CLASS 2.2,
UN1958, LABEL NONFLAMMABLE GAS. SHIPPING CONTAINERS: TANK CARS,
TANK TRUCKS, CYLINDERS.
Regulatory
SARA Title III Information:DISCHLOSURE AS A TOXIC CHEMICAL IS REQUIRED
UNDER SECTION 313 OF TITLE III OF THE SUPERFUND AMENDMENTS AND
REAUTHORIZATION ACT OF 1986 AND 40 CFR PART 372. TITLE III HAZARD
CLASSIFICATIONS SECTIONS 31 1, 312: ACUTE: YES, CHRONIC: NO, FIRE:
NO, REACTIVITY: NO.PRESSURE: NO. LISTS: EXTREMELY HAZARDOUS
SUBSTANCE- NO.CRCLA HAZARDOUS SUBSTANCE - NO. TOXIC CHEMICALS -YES.
Federal Regulatory Information:TSCA INVENTORY STATUS:
REPORTED/INCLUDED.